NCT03273023View on ClinicalTrials.gov

PROMUS PREMIER™ China Post-Approval Study

CompletedOBSERVATIONAL
Enrollment

2,059

Participants

Timeline

Start Date

January 11, 2018

Primary Completion Date

December 28, 2020

Study Completion Date

August 3, 2025

Conditions
Coronary Artery Disease
Interventions
DEVICE

Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System

Promus PREMIERTM Stent System

Trial Locations (1)

Unknown

The Second Affiliated Hospital of Harbin Medical University, Harbin

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY